Thrombopoietic cytokines in patients with hepatitis C virus-associated immune thrombocytopenia

References

• Neunert C, Lim W, Crowther M, Cohen A, Solberg Jr L, Crowther MA, et al. The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. Blood 2011;117(16):4190–207. doi: 10.1182/blood-2010-08-302984
   PubMed Web of Science ®Google Scholar
• Stasi R, Willis F, Shannon MS, Gordon-Smith EC. Infectious causes of chronic immune thrombocytopenia. Hematol Oncol Clin North Am. 2009;23(6):1275–97. doi: 10.1016/j.hoc.2009.08.009
   PubMed Web of Science ®Google Scholar
• Louie KS, Micallef JM, Pimenta JM, Forssen UM. Prevalence of thrombocytopenia among patients with chronic hepatitis C: a systematic review. J Viral Hepat. 2011;18(1):1–7. doi: 10.1111/j.1365-2893.2010.01366.x
   PubMed Web of Science ®Google Scholar
• Rajan SK, Espina BM, Liebman HA. Hepatitis C virus-related thrombocytopenia: clinical and laboratory characteristics compared with chronic immune thrombocytopenic purpura. Br J Haematol. 2005;129(6):818–24. doi: 10.1111/j.1365-2141.2005.05542.x
   PubMed Web of Science ®Google Scholar
• Weksler BB. Review article: the pathophysiology of thrombocytopenia in hepatitis C virus infection and chronic liver disease. Aliment Pharmacol Ther. 2007;26(Suppl 1):13–9. doi: 10.1111/j.1365-2036.2007.03512.x
   PubMed Web of Science ®Google Scholar
• Afdhal NH, McHutchison JG. Review article: pharmacological approaches for the treatment of thrombocytopenia in patients with chronic liver disease and hepatitis C infection. Aliment Pharmacol Ther. 2007;26(Suppl 1):29–39. doi: 10.1111/j.1365-2036.2007.03511.x
   PubMed Web of Science ®Google Scholar
• Tillmann HL, McHutchison JG. Use of thrombopoietic agents for the thrombocytopenia of liver disease. Semin Hematol. 2010;47(3):266–73. doi: 10.1053/j.seminhematol.2010.04.003
   PubMed Web of Science ®Google Scholar
• Aster RH. Pooling of platelets in the spleen: role in the pathogenesis of “hypersplenic” thrombocytopenia. J Clin Invest. 1966;45(5):645–57. doi: 10.1172/JCI105380
   PubMed Web of Science ®Google Scholar
• Zucker ML, Hagedorn CH, Murphy CA, Stanley S, Reid KJ, Skikne BS. Mechanism of thrombocytopenia in chronic hepatitis C as evaluated by the immature platelet fraction. Int J Lab Hematol. 2012;34(5):525–32. doi: 10.1111/j.1751-553X.2012.01429.x
   PubMed Web of Science ®Google Scholar
• Adinolfi LE, Giordano MG, Andreana A, Tripodi MF, Utili R, Cesaro G, et al. Hepatic fibrosis plays a central role in the pathogenesis of thrombocytopenia in patients with chronic viral hepatitis. Br J Haematol. 2001;113(3):590–5. doi: 10.1046/j.1365-2141.2001.02824.x
   PubMed Web of Science ®Google Scholar
• Kaushansky K. Determinants of platelet number and regulation of thrombopoiesis. Hematology Am Soc Hematol Educ Program. 2009:147–52.
   PubMedGoogle Scholar
• Giannini EG. Review article: thrombocytopenia in chronic liver disease and pharmacologic treatment options. Aliment Pharmacol Ther. 2006;23(8):1055–65. doi: 10.1111/j.1365-2036.2006.02889.x
   PubMed Web of Science ®Google Scholar
• Maan R, Veldt BJ, Janssen HL. Eltrombopag for thrombocytopenic patients with chronic HCV infection. Gastroenterol. 2014;147(1):254–5. doi: 10.1053/j.gastro.2014.01.070
   PubMed Web of Science ®Google Scholar
• Lawitz EJ, Hepburn MJ, Casey TJ. A pilot study of interleukin-11 in subjects with chronic hepatitis C and advanced liver disease nonresponsive to antiviral therapy. Am J Gastroenterol. 2004;99(12):2359–64. doi: 10.1111/j.1572-0241.2004.40047.x
   PubMed Web of Science ®Google Scholar
• Cantor SB, Elting LS, Hudson Jr DV, Rubenstein EB. Pharmacoeconomic analysis of oprelvekin (recombinant human interleukin-11) for secondary prophylaxis of thrombocytopenia in solid tumor patients receiving chemotherapy. Cancer 2003;97(12):3099–106. doi: 10.1002/cncr.11447
   PubMed Web of Science ®Google Scholar
• Lee LH, Caguioa P, Chin NS, Chiou TJ, Lee JW, Miyakawa Y, et al. Chronic adult primary immune thrombocytopenia (ITP) in the Asia-Pacific region. Int J Hematol. 2011;94(2):142–9. doi: 10.1007/s12185-011-0894-8
   PubMed Web of Science ®Google Scholar
• Kuter DJ, Gernsheimer TB. Thrombopoietin and platelet production in chronic immune thrombocytopenia. Hematol Oncol Clin North Am. 2009;23(6):1193–211. doi: 10.1016/j.hoc.2009.09.001
   PubMed Web of Science ®Google Scholar
• Pradella P, Bonetto S, Turchetto S, Uxa L, Comar C, Zorat F, et al. Platelet production and destruction in liver cirrhosis. J Hepatol. 2011;54(5):894–900. doi: 10.1016/j.jhep.2010.08.018
   PubMed Web of Science ®Google Scholar
• Aref S, Mabed M, Selim T, Goda T, Khafagy N. Thrombopoietin (TPO) levels in hepatic patients with thrombocytopenia. Hematology 2004;9(5–6):351–6. doi: 10.1080/10245330400010620
   PubMedGoogle Scholar
• Grozovsky R, Begonja AJ, Liu K, Visner G, Hartwig JH, Falet H, et al. The Ashwell-Morell receptor regulates hepatic thrombopoietin production via JAK2-STAT3 signaling. Nat Med. 2015;21(1):47–54. doi: 10.1038/nm.3770
   PubMed Web of Science ®Google Scholar
• Akira S, Taga T, Kishimoto T. Interleukin-6 in biology and medicine. Adv Immunol. 1993;54:1–78. doi: 10.1016/S0065-2776(08)60532-5
   PubMed Web of Science ®Google Scholar
• Kaser A, Brandacher G, Steurer W, Kaser S, Offner FA, Zoller H, et al. Interleukin-6 stimulates thrombopoiesis through thrombopoietin: role in inflammatory thrombocytosis. Blood 2001;98(9):2720–5. doi: 10.1182/blood.V98.9.2720
   PubMed Web of Science ®Google Scholar
• Lu H, Jiang T, Li R, Wang S, Zhang Q, Zhao S. Bone marrow stromal cells transduced with a thrombopoietin, interleukin-6, and interleukin-11 syncretic gene induce cord mononuclear cells to generate platelets in vitro. Transfusion 2015;55(1):176–86. doi: 10.1111/trf.12800
   PubMed Web of Science ®Google Scholar
• Eulenfeld R, Dittrich A, Khouri C, Muller PJ, Mutze B, Wolf A, et al. Interleukin-6 signalling: more than Jaks and STATs. Eur J Cell Biol. 2012;91(6–7):486–95. doi: 10.1016/j.ejcb.2011.09.010
   PubMed Web of Science ®Google Scholar
• Kosar A, Haznedaroglu IC, Buyukasik Y, Ozcebe O, Kirazli S, Dundar S. Circulating thrombopoietin and interleukin-6 in newly diagnosed autoimmune versus aplastic thrombocytopenia. Haematologica 1998;83(11):1055–6.
   PubMed Web of Science ®Google Scholar
• Tepler I, Elias L, Smith 2nd JW, Hussein M, Rosen G, Chang AY, et al. A randomized placebo-controlled trial of recombinant human interleukin-11 in cancer patients with severe thrombocytopenia due to chemotherapy. Blood 1996;87(9):3607–14.
   PubMed Web of Science ®Google Scholar
• Peck-Radosavljevic M, Zacherl J, Wichlas M, Sims P, Meng YG, Panzer S, et al. Thrombopoietic cytokines and reversal of thrombocytopenia after liver transplantation. Eur J Gastroenterol Hepatol. 1999;11(2):151–6. doi: 10.1097/00042737-199902000-00015
   PubMed Web of Science ®Google Scholar
• Chang M, Suen Y, Meng G, Buzby JS, Bussel J, Shen V, et al. Differential mechanisms in the regulation of endogenous levels of thrombopoietin and interleukin-11 during thrombocytopenia: insight into the regulation of platelet production. Blood 1996;88(9):3354–62.
   PubMed Web of Science ®Google Scholar
• Du X, Williams DA. Interleukin-11: review of molecular, cell biology, and clinical use. Blood 1997;89(11):3897–908.
   PubMed Web of Science ®Google Scholar
• Sakakura C, Hagiwara A, Taniguchi H, Yamaguchi T, Yamagishi H, Takahashi T, et al. Chromosomal aberrations in human hepatocellular carcinomas associated with hepatitis C virus infection detected by comparative genomic hybridization. Br J Cancer. 1999;80(12):2034–9. doi: 10.1038/sj.bjc.6690638
   PubMed Web of Science ®Google Scholar
• Kondo Y, Kanai Y, Sakamoto M, Mizokami M, Ueda R, Hirohashi S. Genetic instability and aberrant DNA methylation in chronic hepatitis and cirrhosis – A comprehensive study of loss of heterozygosity and microsatellite instability at 39 loci and DNA hypermethylation on 8 CpG islands in microdissected specimens from patients with hepatocellular carcinoma. Hepatology 2000;32(5):970–9. doi: 10.1053/jhep.2000.19797
   PubMed Web of Science ®Google Scholar
• Bessissow T, Renard M, Hoffman I, Vermeire S, Rutgeerts P, Van Assche G. Review article: non-malignant haematological complications of anti-tumour necrosis factor alpha therapy. Aliment Pharmacol Ther. 2012;36(4):312–23. doi: 10.1111/j.1365-2036.2012.05189.x
   PubMed Web of Science ®Google Scholar
• Piguet PF, Vesin C, Da Kan C. Activation of platelet caspases by TNF and its consequences for kinetics. Cytokine 2002;18(4):222–30. doi: 10.1006/cyto.2002.0889
   PubMed Web of Science ®Google Scholar
• Tawadrous GA, Aziz AA, Amin DG, Eldemery A, Mostafa MA. RANTES, TNF-α, oxidative stress, and hematological abnormalities in hepatitis C virus infection. J Invest Med. 2012;60(6):878–82. doi: 10.2310/JIM.0b013e318254519e
   PubMed Web of Science ®Google Scholar